Exemestane 25 - Livewell Pharmaceuticals

Introduced by Pharmacia in 2000 as Aromasin, Exemestane quickly became a globally marketed anti-estrogen. Its irreversible inhibition of aromatase distinguishes it from other drugs in its class. Exemestane is effective in treating estrogen-positive breast cancer in postmenopausal women unresponsive to tamoxifen. It’s typically supplied in 25 mg tablets and lowers serum estrogen by about 85%. Though originally a cancer therapy, Exemestane gained use among male steroid users for reducing estrogenic complications and preserving muscle definition.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Exemestane 25 by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.